AMA CPT® Assistant - 2022 Issue 7 (July)
New COVID-19 Vaccine Codes: July Update (July Special Update 2022)
July Special Update 2022 page 1 New COVID-19 Vaccine Codes: July Update The Current Procedural Terminology (CPT®) Editorial Panel (the Panel) has approved three new vaccine administration codes (0091A, 0092A, 0093A) for the Moderna vaccine product to address severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease 2019 [COVID-19]) in pediatric patients aged 6 through 11 years. These codes are to be reported with previously established Moderna vaccine product code 91309. The Panel has also approved an additional vaccine administration code (0113A) that is to be reported with the previously established Moderna vaccine product (91311) for pediatric patients...
Subscribe or sign in to view the full article.
Article Overview
This CPT® Assistant Special Edition update explains July 2022 changes to Moderna COVID-19 vaccine product and administration coding. It is relevant to coders, billers, and clinical documentation teams working with immunization reporting, CPT code updates, and Appendix Q references. The article covers newly established administration codes, revised age applicability for existing codes, related CPT editorial updates, and the role of Appendix Q in organizing vaccine coding guidance.
Why This Topic Matters
COVID-19 vaccine coding changed quickly during 2022, and this update helps users recognize which CPT® vaccine products and administration codes were newly added or revised. It also highlights where the code-set guidance was organized and how the changes were reflected in supporting CPT reference materials.
Article Sections
-
July Special Update 2022 page 1
Introduces the July 2022 CPT® vaccine coding update and summarizes the scope of the Moderna-related changes discussed in the article.
-
Immunization Administration for Vaccines/Toxoids
Presents the updated Moderna immunization administration codes and their associated vaccine product references. It also notes age-related applicability and related CPT parenthetical guidance.
-
Vaccines, Toxoids
Lists the Moderna vaccine product codes discussed in the update and the administration codes linked to each product. This section also reflects the age-group revisions covered in the article.
-
Table 1 Excerpt from Appendix Q: Moderna COVID-19 Vaccine Codes*
Shows an excerpt of Appendix Q organizing Moderna vaccine product codes, associated administration codes, and patient age categories. The table highlights the coding changes addressed in the article.
-
Clinical Example (0091A) / Description of Procedure (0091A)
Provides a clinical scenario and procedural context for one of the newly discussed Moderna pediatric administration codes.
-
Clinical Example (0092A) / Description of Procedure (0092A)
Provides a clinical scenario and procedural context for one of the newly discussed Moderna pediatric administration codes.
-
Clinical Example (0093A) / Description of Procedure (0093A)
Provides a clinical scenario and procedural context for one of the newly discussed Moderna pediatric administration codes.
-
Clinical Example (0113A) / Description of Procedure (0113A)
Provides a clinical scenario and procedural context for one of the newly discussed Moderna pediatric administration codes.
What You Will Learn
- How the July 2022 CPT® update organized Moderna COVID-19 vaccine coding changes
- Which areas of the CPT code set were revised for pediatric and adult vaccine reporting
- How Appendix Q is used to summarize vaccine product and administration code relationships
- What categories of guidance are included in the special edition update
Who Should Read This
- Medical coders
- Billing staff
- Compliance teams
- Clinical documentation specialists
- Practice managers
- Immunization reporting staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com
